When — Not What — Obese Mice Ate Reduced Breast Cancer Risk
January 25, 2021
University of California San Diego School of Medicine and Moores Cancer Center researchers report that intermittent fasting reduced breast cancer risk in obese mice.
Your search for “Lung Metastasis” returned 24 results
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
September 16, 2014
Researchers at the University of California, San Diego School of Medicine have launched a phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for patients with chronic lymphocytic leukemia (CLL), the most common form of blood cancer in adults.
UC San Diego Researchers Convert Pro-Tumor Macrophages into Cancer Killers
August 21, 2019
University of California San Diego School of Medicine researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
UC San Diego Cancer Researchers Receive $4 Million CIRM Disease-Team Grant
December 13, 2013
Researcher Thomas J. Kipps, MD, PhD, professor of medicine and deputy director of research operations at UC San Diego Moores Cancer Center, is principal investigator for one of six “Disease Team” awards approved December 12 by the governing board of the California Institute for Regenerative Medicine (CIRM).
Stress-Tolerant Cells Drive Tumor Initiation in Pancreatic Cancer
January 17, 2023
UC San Diego scientists discover a molecular pathway critical to the initiation of pancreatic tumors. The findings may inspire new chemotherapeutic drugs targeting early stages of tumor formation and spread
Prevention and Screening Clinic at UC San Diego Health Helping to Reduce Pancreatic Cancer
November 29, 2018
Moores Cancer Center at UC San Diego Health launched the Pancreatic Cancer Prevention and Screening Clinic in an attempt to reduce the number of people who develop the disease and improve survival for those who do. Every day in the U.S., 145 people are diagnosed and every 12 minutes someone…
Appendiceal Cancer Gets Its Own Preclinical Model
November 1, 2022
Researchers at UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe the first preclinical model of appendiceal cancer that contains all elements of the tumor, allowing previously stymied investigations to proceed.
Powered by Chemo: Patient with Advanced Pancreatic Cancer Tackles Ironman Triathlon
October 10, 2017
Despite a diagnosis of stage IV pancreatic cancer and ongoing chemotherapy, Mike Levine boarded a plane this past weekend destined for Kona, Hawaii, where he will compete in one of the most grueling of physical competitions: the Ironman World Championship. Cheering him on will be his wife Jan, friends and…
UC San Diego Researcher Gets $4 Million NCI Award to Study Cancer Drug Resistance, Spread
December 7, 2018
David Cheresh, Distinguished Professor at University of California San Diego School of Medicine, received $4.2 million National Cancer Institute Outstanding Investigator Award to continue his research into cancer’s ability to overcome stress, gain drug resistance and metastasize.
Researchers Discover Specific Tumor Environment That Triggers Cells to Metastasize
November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells are confined in a dense environment, the researchers found that they turn on a specific set of genes…
